Role of methemoglobin and carboxyhemoglobin levels in predicting COVID-19 prognosis: an observational study.

World Health Organization has declared coronavirus disease-19 (COVID-19) as a pandemic. Although there are studies about this novel virus, our knowledge is still limited. There is limited information about its diagnosis, treatment and prognosis. We aimed to investigate the effect of methemoglobin and carboxyhemoglobin levels on the prognosis of COVID-19. In this observational study, patients who were diagnosed with COVID-19 during March 1-April 31, 2020 in a secondary-level state hospital in Turkey were included in the study. COVID-19 diagnosis was confirmed with reverse transcription polymerase chain reaction method, with nasal, oral or sputum specimens. During the period this study was performed, 3075 patients were tested for COVID-19 and 573 of them were hospitalized. Among the hospitalised patients, 23.2% (133) of them had a positive polymerase chain reaction result for COVID-19. A total of 125 patients, 66 (52.8%) males and 59 (47.2%) females, with an average age of 50.2 ± 19.8 years, were included in the study. The most common findings in chest radiogram were ground-glass areas and consolidations, while one-third of the patients had a normal chest radiogram. Computed thorax tomography was performed for 77.6% (97/125) of the patients. The 24.7% of computed tomographies (24/97) did not reveal any pathological findings, and the most common findings were ground-glass appearance and consolidation. Those who needed intensive care had statistically significantly lower platelet count (P = 0.011) and higher lactate dehydrogenase levels (P < 0.001). No statistically significant difference was found in carboxyhemoglobin (P = 0.395) and methemoglobin (P = 1.000) levels. We found that carboxyhemoglobin and methemoglobin levels had no effect on COVID-19 prognosis, but low platelet level played a role in predicting COVID-19 prognosis. This study was approved by the Ethical Committee of Harran University Faculty of Medicine on May 11, 2020 with approval No. 09.

Effect of accreditation and certification on the quality management system: Analysis based on Turkish hospitals.

Effects of certification and accreditation on hospital quality management systems (QMS) are measured to better understand the value of external recognitions. This study identifies the QMS dimensions that show significant improvements with hospital certification and/or accreditation. Data were collected from 350 Turkish hospitals using a structured questionnaire. Mean scores of nine domains of QMS were used as outcome variables. Although quality policy documents, quality monitoring by board, and training of professionals are the focus of generic QMS, ISO certification did not affect these scores significantly. Formal protocols for infection control scores are affected by hospital size and certification status. Adoption of Ministry of Health's (MOH) infection control initiatives has improved this score for all hospital types. Formal protocols for medication and patient handling, analyzing performance of care processes, and evaluating results improved with accreditation and certification status. Larger hospitals were better able to implement application of protocols, analyzing care process and evaluating results. For improvements in the QMS scores, external assessments are valuable, but quality-focused governmental regulations appear important for improving QMS of small and medium-sized hospitals. Higher QMS scores, however, may not lead to improved quality. Future studies should explore the relationship between QMS scores and service quality.

Management of pneumothorax in emergency medicine departments: multicenter trial.

BACKGROUND: Pneumothorax is common and life-threatening clinical condition which may require emergency treatment in Emergency Medicine Departments. OBJECTIVES: We aimed to reveal the epidemiological analysis of the patients admitted to the Emergency Department with pneumothorax. MATERIAL AND METHODS: This case-control and multi-center study was conducted in the patients treated with the diagnosis of pneumothorax between 01.01.2010-31.12.2010. Patient data were collected from hospital automation system. According to the etiology of the pneumothorax, study groups were arranged like spontaneous pneumothorax and traumatic pneumothorax. RESULTS: 82.2% (n = 106) of patients were male and 17.8% (n = 23) of patients were female and mean age were 31.3 ± 20,2 (Minimum: 1, Maximum: 87). 68.2% (n = 88) of patients were spontaneous pneumothorax (61.36%, n=79 were primary spontaneous pneumothorax) and 31.8% (n = 41) of patients were traumatic pneumothorax (21.95% were iatrogenic pneumothorax). Main complaint is shortness of breath (52.3%, n=67) and 38% (n=49) of patients were smokers. Posteroanterior (PA) Chest X-Ray has been enough for 64.3% (n = 83) of the patients' diagnosis. Tube thoracostomy is applied to 84.5% (n = 109) of patients and surgery is applied to 9.3% (n = 12) of patients and 6.2% (n = 8) of patients were discharged with conservative treatment. Spontaneous pneumothorax showed statistically significant high recurrence compared with traumatic pneumothorax (P = 0.007). 4.65% of (n = 6) patients died. The average age of those who died (9.3 ± 19.9), statistically were significantly lower the mean age of living patients (32.4 ± 19.7) (t test, P = 0,006). 83.33% of the patients who died were neonatals and in the 0-1 years age group, and five of these patients were secondary spontaneous pneumothorax, and one of these patients were iatrogenic pneumothorax due to mechanical ventilation. CONCLUSIONS: Pneumothorax in adults can be treated by tube thoracostomy or surgically. Despite treatment, mortality of secondary and iatrogenic pneumothorax in newborns and 0-1 years age group is high.